Feasibility and Safety of Single-Port Video-Assisted Thoracic Surgery for Primary Lung Cancer

´ëÇÑÈäºÎ¿Ü°úÇÐȸÁö 2017³â 50±Ç 3È£ p.190 ~ p.196

Çã¿î(Heo Woon) - Inje University College of Medicine Haeundae Paik Hospital Department of Thoracic and Cardiovascular Surgery
°­µµ±Õ(Kang Do-Kyun) - Inje University College of Medicine Haeundae Paik Hospital Department of Thoracic and Cardiovascular Surgery
¹ÎÈ£±â(Min Ho-Ki) - Inje University College of Medicine Haeundae Paik Hospital Department of Thoracic and Cardiovascular Surgery
ÀüÈñÀç(Jun Hee-Jae) - Inje University College of Medicine Haeundae Paik Hospital Department of Thoracic and Cardiovascular Surgery
ȲÀ±È£(Hwang Youn-Ho) - Inje University College of Medicine Haeundae Paik Hospital Department of Thoracic and Cardiovascular Surgery

Abstract

Background: The feasibility of single-port video-assisted thoracic surgery (SPVATS) for primary lung cancer is not well understood. In this study, we compared SP and multi-port (MP) VATS for the surgical treatment of patients with primary lung cancer.

Methods: Surgical treatment was performed in 181 patients with primary lung cancer at Inje University Haeundae Paik Hospital between June 2012 and December 2015. A propensity-matched analysis was used to compare the postoperative outcomes and to evaluate the comparative feasibility and safety of SPVATS and MPVATS.

Results: There were 37 patients in the SPVATS group and 67 patients in the MPVATS group. Propensity matching produced 32 pairs. The operation time (210 minutes versus 200 minutes, p=0.11), volume of the estimated blood loss (170 mL versus 160 mL, p=0.19), duration of chest tube drainage (5 days versus 6 days, p=0.66), and length of hospital stay (9 days versus 10 days, p=0.89) were similar between the 2 groups.

Conclusion: In our study, SPVATS for primary lung cancer was safe and feasible in well selected patients. A prospective, randomized study with a large group and long-term follow-up is necessary to evaluate the clinical feasibility and the advantages of SPVATS for primary lung cancer.

Å°¿öµå

Video-assisted thoracic surgery, Lung neoplasms, Lobectomy
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
SPVATS for primary lung cancer is safe and feasible in well-selected patients.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå